Apply Early
The NIDCD encourages applicants to submit application 30 days in advance of the deadline. This will allow time to work through unforeseen issues.
Choose the Appropriate Funding Opportunity
Applying to an inappropriate funding opportunity may result in your application being returned.
Correctly identifying whether a study is a clinical trial is crucial to:
- Picking the right funding opportunity.
- Ensuring that applications include the required information for peer review.
- Complying with appropriate policies and regulations.
Therefore, it is important to submit your application early.
Determine if a Funding Opportunity Accepts Clinical Trials
Effective for due dates on or after January 25, 2018, if your application contains a clinical trial, you must apply to a funding opportunity that specifies one of the following:
- “Clinical Trial Optional”
- “Clinical Trial Required”
All funding opportunities will specify the allowability of clinical trials applications in the title and in a new row in section II, as shown below:
FOA Title (new FOAs only)
Participating Organization(s)
National Institutes of Health (NIH)
Components of Participating Organizations
National Cancer Institute (NCI)
Funding Opportunity Title (new funding opportunities only)
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)
Funding Opportunity Section II. Award Information
Application Types Allowed
New
Resubmission
Revision
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.
Clinical Trial?
Required: Only accepting applications that propose clinical trial(s)
Need help determining whether you are doing a clinical trial?